12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Vaxcyte Inc. (PCVX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 8,689,190 | $711,297,093 | 9.46% | |
| 2. | Kynam Capital Derrick Tang | 2,336,796 | $191,290,121 | +125% | 11.3% |
| 3. | Perceptive Advisors Joseph Edelman | 1,718,417 | $140,669,616 | -16% | 3.87% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,625,000 | $133,022,500 | +77% | 9.74% |
| 5. | Maverick Capital Lee Ainslie | 1,201,898 | $98,387,370 | +24% | 1.77% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 937,500 | Large Shareholder | 5,156,553 | 2020-06-16 | Filing | |
| $16.00 | 12,500 | Director | 4,168,718 | 2020-06-16 | Filing | |
| $16.00 | 93,000 | Director | 2,222,967 | 2020-06-16 | Filing | |
| $16.00 | 250,000 | Director | 2,309,554 | 2020-06-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.58 | 1,818 | Officer | 109,491 | 2025-02-18 | Filing | |
| $83.64 | 6,182 | Officer | 111,309 | 2025-02-18 | Filing | |
| $91.71 | 255 | Officer | 28,222 | 2025-02-05 | Filing | |
| $91.05 | 1,784 | Officer | 28,477 | 2025-02-05 | Filing | |
| $89.95 | 1,755 | Officer | 30,261 | 2025-02-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,091,648 | $1,071,682,283 | 0.06% | |
| 2. | 11,961,687 | $979,183,698 | 0.01% | |
| 3. | 11,106,069 | $909,142,808 | 0.01% | |
| 4. | 10,575,363 | $865,605,331 | 0.43% | |
| 5. | 6,210,523 | $508,393,413 | 0.1% |
News See All
10 Best Russell 2000 Stocks to Invest in According to Analysts
The Russell 2000 Index is a widely followed benchmark that tracks the performance of small-cap companies in the United States.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
What Makes Vaxcyte (PCVX) An Investment Bet?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter.
Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Consider Investing in Vaxcyte (PCVX)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, everyone. My name is Bo and I will be your conference operator today.
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, everyone. My name is Bo and I will be your conference operator today.
Billionaire Hedge Funds
